High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles

High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles

Bibliographic Details
Main Authors: Kin Man Au, Rod Balhorn, Monique C. Balhorn, Steven I. Park, Andrew Z. Wang
Format: Article
Language:English
Published: American Chemical Society 2018-12-01
Series:ACS Central Science
Online Access:https://doi.org/10.1021/acscentsci.8b00746

Internet

https://doi.org/10.1021/acscentsci.8b00746

Similar Items